Decheng Capital
About Us
Team
Portfolio
News
Contact
A Global Life Sciences Investment Firm
Established in 2012
$2.1 Billion of Capital
Building Legendary Companies
In The News
August 25, 2015
BD to Acquire Cellular Research to Develop a Leading Genomics Platform for Single Cell Analysis
August 13, 2015
Roche Acquires GeneWEAVE to Strengthen Offerings in Microbiology Diagnostics
May 26, 2015
3SBio Attracts GIC, BlackRock to $712 Million Hong Kong IPO
February 12, 2015
Invitae's $102M IPO Stands Alone as Three Medtech IPOs Remain Sidelined
Archive
2022
2021
2019
2018
2017
2016
2015
2014
2013
2012
